|
Volumn 312, Issue 20, 2014, Pages 2168-2169
|
In reply
|
Author keywords
[No Author keywords available]
|
Indexed keywords
SOFOSBUVIR;
ANTIVIRUS AGENT;
COST EFFECTIVENESS ANALYSIS;
DRUG COST;
DRUG MARKETING;
INVESTMENT;
LETTER;
PURCHASING;
ECONOMICS;
HEPATITIS C, CHRONIC;
HUMAN;
ANTIVIRAL AGENTS;
DRUG COSTS;
HEPATITIS C, CHRONIC;
HUMANS;
|
EID: 84914100196
PISSN: 00987484
EISSN: 15383598
Source Type: Journal
DOI: 10.1001/jama.2014.14352 Document Type: Letter |
Times cited : (1)
|
References (0)
|